We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Davide D’Amico is an experienced Medical Biotechnologist (MSc, University of Bologna - Italy) and business executive in life science. He started his research activity 11 years ago, as a pre-doctoral researcher in the University of Florida (USA) and followed as PhD student in the Centre for Genomic Regulation (Barcelona – Spain), in the field of neuroscience. Since 2013, after his PhD, Davide is Co-founder and Chief Executive Officer at ZeClinics, where he is responsible of the guide and management of the company vision, strategy and future plan. Davide has experience in management and startup growth, coordinating today ZeClinics’ asset of 24 FTEs, collected private and public funding for almost €3M. Moreover, he leads the busines orientation of internal R&D projects and of the commercial activity of the company, with global clients in pharma and academia. He has presented in more than 20 international and national congresses and has been awarded with several prizes and fellowships.
This speaker's sessions: